Baxter International, Inc. (NYSE:BAX)

BetterMoney77 (< 20) Submitted: 12/7/2007 12:28:16 PM : Start Price: $55.00 BAX Score: +3.02

Solid old company. They are expanding plasma based drug manufacturing.

KNsurfer (68.64) Submitted: 10/5/2007 10:51:44 PM : Start Price: $51.10 BAX Score: +12.68

:)

mouse6196 (67.09) Submitted: 9/4/2007 11:01:45 PM : Start Price: $48.93 BAX Score: +12.42

I have some hope on their latest alzheimers study initiatives.

Robnic1 (50.22) Submitted: 9/1/2007 1:49:22 AM : Start Price: $49.30 BAX Score: +11.16

Alwayas a favorite. I see $60 to $65 a share before years end.

Vaquero12 (71.53) Submitted: 6/24/2007 9:45:45 AM : Start Price: $50.75 BAX Score: +9.89

current conditions make this a good buy

KingMinusTouch (< 20) Submitted: 5/31/2007 1:41:09 AM : Start Price: $51.51 BAX Score: +10.03

I own some

gwoope (74.53) Submitted: 5/25/2007 1:52:57 AM : Start Price: $51.50 BAX Score: +8.77

macd

jnbvasc (87.55) Submitted: 4/29/2007 4:51:31 AM : Start Price: $51.87 BAX Score: +6.91

Excellent product

harrison5048 (66.16) Submitted: 3/16/2007 4:20:15 PM : Start Price: $46.55 BAX Score: +11.39

more old people

DGonce (26.52) Submitted: 3/12/2007 2:44:05 PM : Start Price: $45.88 BAX Score: +14.07

health related stocks are leading the way after the recent correction. BAX jumped after 4th Qtr profits increased 48% on an 11% increase in sales. its Bioscience division led the way followed by the Medication Delivery and Renal divisions. VV valued at 60

mtthwpigott (95.15) Submitted: 2/11/2007 10:37:15 PM : Start Price: $44.90 BAX Score: +18.39

at this point with the mix up its having with its contract on manufacturing vaccines it may not be a good buy. Eventually when this is over, it will continue to produce and if the CEO is still doing a great job this company will grow bigger and bigger.

jchap1212 (74.54) Submitted: 2/2/2007 9:29:20 PM : Start Price: $44.70 BAX Score: +19.42

already winning - good solid core

cmmtx (85.34) Submitted: 12/19/2006 8:27:23 PM : Start Price: $41.98 BAX Score: +25.31

A

mschluter (< 20) Submitted: 12/12/2006 10:43:53 PM : Start Price: $40.59 BAX Score: +29.50

Current epidemic of diabetes will increase kidney disease and dialysis

extremeinvesting (97.25) Submitted: 10/30/2006 6:53:28 PM : Start Price: $41.89 BAX Score: +22.58

BAX has been around for 75 years in the industry and continues to expand its niche. With great 3Q 2006 reports, this company continues to provide the long term investor something to smile about. The recent news about re-categorizing one of its drugs may cost the company legal money to pursue, but in the long term, this extreme performance investing stock should continue to rise to/remain at the top of its sector